The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005
The six-minute walk test in cystic fibrosis: a comparison to lung function Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment Year: 2009
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1823-1824 Year: 2014
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1822-1823 Year: 2014
Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – IPF: clinical aspects Year: 2015
Cystic fibrosis patients: do they profit from altitiude residence? Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases Year: 2006
Is there a relationship between walk distance and lung function parameters in different disease groups? Can we predict walk distance? Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012
The relationship between the shuttle walk test, lung function and BMI in patients with sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Source: Eur Respir J 2004; 23: 28-33 Year: 2004
Which equations to estimate peak work rate from six minute walk test in patients with cystic fibrosis post lung transplantation? Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Can step be a maximal test in children with cystic fibrosis? Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis Source: Eur Respir J 2001; 17: 712-715 Year: 2001
Differences between six minute walk test values with obstructed and non obstructed cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 698s Year: 2004
Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1421-1429 Year: 2014
Challenges in idiopathic pulmonary fibrosis trials: the point on end-points Source: Eur Respir Rev 2011; 20: 195-200 Year: 2011
What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases? Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009
The impact of a new reference value set for diffusing capacity for patients with idiopathic pulmonary fibrosis. Source: International Congress 2018 – Quality, reference values and standards Year: 2018
The relationship between pulmonary function, health status, shuttle walk distance with sputum airway inflammation in moderate-to-severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 94s Year: 2001